Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Woo

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cell Death & Disease|June 8, 2012
Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibitionH-O Jin, S-E Hong, S-H Woo, et al.
International Journal of Cardiology. Heart & Vasculature|October 24, 2022
Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical riskRazina A Ahmed, Zhuqing Shi, Andrew S Rifkin, et al.
Oncogene|April 5, 2011
TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1H-O Jin, S-K Seo, Y-S Kim, et al.
Thrombosis Research|July 7, 2023
Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohortZhuqing Shi, Jun Wei, Andrew S Rifkin, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cell Death & Disease|June 8, 2012
Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibitionH-O Jin, S-E Hong, S-H Woo, et al.
International Journal of Cardiology. Heart & Vasculature|October 24, 2022
Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical riskRazina A Ahmed, Zhuqing Shi, Andrew S Rifkin, et al.
Oncogene|April 5, 2011
TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1H-O Jin, S-K Seo, Y-S Kim, et al.
Thrombosis Research|July 7, 2023
Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohortZhuqing Shi, Jun Wei, Andrew S Rifkin, et al.
Pageof 6